The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Open accessAbstract
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alphabeta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alphabeta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, it is no surprise that IFN-β transcriptome signatures were found to be associated with active but not latent TB (101).”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baechler, E. C., Batliwalla, F., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M. H., Kapur, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337679100 · Cited by 2,246
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L. B., Palucka, K., Arce, E., Cantrell, V., Borvák, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,990
Self-citationBlood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
Auffray, C., Sieweke, M. H., & Geissmann, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132557 · Cited by 1,744
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V. A., Dick, T., Ehrt, S., Flynn, J. L., Schnappinger, D., Wilkinson, R. J., & Young, D. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,441
Self-citationCell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Chaussabel, D., Quinn, C., Shen, J., Patel, P., Glaser, C., Baldwin, N., Stichweh, D., Blankenship, D., Li, L., Munagala, I., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.012 · Cited by 649
Self-citationImmunisation against infectious disease
SALISBURY, D. M., Ramsay, M. E., & Noakes, K. (2006) · Stationery Office eBooks · Cited by 636
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636
Flagged first, then by citations
Research works printed but not linked: 2
- Dye, C., Floyd, K. & Uplekar, M. in Global Tuberculosis Control: Surveillance, Planning, Financing Ch. 1, 17–37 (World Health Organization, 2008)
- Falk, A. & O’Connor, J. B. in Diagnosis Standards and Classification of Tuberculosis, vol. 12 (eds Falk, A. et al.), 68–76 (National Tuberculosis and Respiratory Disease Association, 1969)
Cited by
Sorted by citations
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3024 · Cited by 3,045
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Self-citationThe Immune Response in Tuberculosis
O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,400
Self-citationPai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
The multifaceted biology of plasmacytoid dendritic cells
Swiecki, M. K., & Colonna, M. (2015) · Nature reviews. Immunology · doi:10.1038/nri3865 · Cited by 1,194
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, É., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,063
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989
Antitumour actions of interferons: implications for cancer therapy
Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.14 · Cited by 920
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A. A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K. U. J., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 881
INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
Rusinova, I., Forster, S., Yu, S., Kannan, A., Masse, M., Cumming, H., Chapman, R., & Hertzog, P. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1215 · Cited by 878
Autophagy in inflammation, infection, and immunometabolism
Deretic, V. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.018 · Cited by 862
ISG15 in antiviral immunity and beyond
Perng, Y.-C., & Lenschow, D. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0020-5 · Cited by 855
Type I interferon: friend or foe?
Trinchieri, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 838
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn‐Nicholson, A., Scriba, T. J., Thompson, E. G., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W. E., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 779
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 804
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 757
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Banchereau, R., Hong, S., Cantarel, B. L., Baldwin, N. E., Baisch, J. M., Edens, M., Cepika, A., Acs, P., Turner, J., Anguiano, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.008 · Cited by 751
Self-citationDiverse novel functions of neutrophils in immunity, inflammation, and beyond
Mócsai, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122220 · Cited by 706
Watson, R. O., Bell, S. L., MacDuff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J., Vance, R. E., Stallings, C. L., Virgin, H. W., & Cox, J. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.004 · Cited by 645
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 659
Immune evasion and provocation by Mycobacterium tuberculosis
Chandra, P., Grigsby, S. J., & Philips, J. A. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00763-4 · Cited by 652
Dheda, K. U. J., Barry, C. E., & Maartens, G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 640
The immunological life cycle of tuberculosis
Ernst, J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3259 · Cited by 598
Drain, P. K., Bajema, K. L., Dowdy, D. W., Dheda, K. U. J., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E. W., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 587
Autophagy balances inflammation in innate immunity
Deretic, V., & Levine, B. (2018) · Autophagy · doi:10.1080/15548627.2017.1402992 · Cited by 563
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M. S., Yu, W., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C. J., Leung, V. W. Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 560
Metformin as adjunct antituberculosis therapy
Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009885 · Cited by 547
Wilkinson, R. J., Rohlwink, U. K., Misra, U. K., van Crevel, R., Hoang, N. T., Dooley, K. E., Caws, M., Figaji, A., Savić, R. M., Solomons, R., et al. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.120 · Cited by 507
Self-citationMolecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
Crawford, A., Angelosanto, J., Kao, C., Doering, T. A., Odorizzi, P. M., Barnett, B. E., & Wherry, E. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.005 · Cited by 513
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Cadena, A. M., Fortune, S. M., & Flynn, J. L. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.69 · Cited by 502
Immunological biomarkers of tuberculosis
Walzl, G., Ronacher, K., Hanekom, W. A., Scriba, T. J., & Zumla, A. I. (2011) · Nature reviews. Immunology · doi:10.1038/nri2960 · Cited by 476
Host and Environmental Factors Influencing Individual Human Cytokine Responses
ter Horst, R., Jaeger, M., Smeekens, S. P., Oosting, M., Swertz, M. A., Li, Y., Kumar, V., Diavatopoulos, D. A., Jansen, A. F. M., Lemmers, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.018 · Cited by 473
Manzanillo, P. S., Shiloh, M. U., Portnoy, D. A., & Cox, J. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.007 · Cited by 467
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
Ottenhoff, T. H. M., & Kaufmann, S. H. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002607 · Cited by 467
Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation
Castillo, E. F., Dekonenko, A., Arko‐Mensah, J., Mandell, M. A., Dupont, N., Jiang, S., Delgado-Vargas, M., Timmins, G. S., Bhattacharya, D., Yang, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210500109 · Cited by 462
Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis
Sweeney, T. E., Braviak, L., Tato, C. M., & Khatri, P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00048-5 · Cited by 435
Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis
Cambier, C. J., Falkow, S., & Ramakrishnan, L. (2014) · Cell · doi:10.1016/j.cell.2014.11.024 · Cited by 454
Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A. (2011) · Immunity · doi:10.1016/j.immuni.2011.12.002 · Cited by 418
Chiche, L., Jourde‐Chiche, N., Whalen, E., Presnell, S., Gersuk, V. H., Dang, K. K., Anguiano, E., Quinn, C., Burtey, S., Berland, Y., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38628 · Cited by 416
Self-citationMacrophages and control of granulomatous inflammation in tuberculosis
Flynn, J. L., Chan, J., & Lin, P. L. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.14 · Cited by 427
Tuberculosis Pathogenesis and Immunity
Philips, J. A., & Ernst, J. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132458 · Cited by 438
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 432
Gebreyes, W. A., Dupouy‐Camet, J., Newport, M. J., de Oliveira, C. J. B., Schlesinger, L. S., Saif, Y. Μ., Kariuki, S., Saif, L. J., Saville, W. J. A., Wittum, T. E., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003257 · Cited by 404
Impact of vitamin D on immune function: lessons learned from genome-wide analysis
Chun, R. F., Liu, P. T., Modlin, R. L., Adams, J. S., & Hewison, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00151 · Cited by 413
Wassermann, R., Gulen, M. F., Sala, C., Perin, S. G., Lou, Y., Rybniker, J., Schmid-Burgk, J. L., Schmidt, T., Hornung, V., Cole, S. T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.003 · Cited by 401
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Bell, L. C. K., & Noursadeghi, M. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.128 · Cited by 416
25-Hydroxycholesterols in innate and adaptive immunity
Cyster, J. G., Dang, E. V., Reboldi, A., & Yi, T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3755 · Cited by 388
Harari, A., Rozot, V., Enders, F. B., Perreau, M., Mazza‐Stalder, J., Nicod, L. P., Cavassini, M. L., Calandra, T., Lazor‐Blanchet, C., Jaton, K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2299 · Cited by 386
Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis
Collins, A. C., Cai, H., Li, T., Franco, L. H., Li, X.-D., Nair, V. R., Scharn, C. R., Stamm, C. E., Levine, B., Chen, Z. J., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.005 · Cited by 402
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303657 · Cited by 379
Self-citationType I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses
Teles, R. M. B., Graeber, T. G., Krutzik, S. R., Montoya, D. J., Schenk, M., Lee, D. J., Komisopoulou, E., Kelly‐Scumpia, K. M., Chun, R. F., Iyer, S. S., et al. (2013) · Science · doi:10.1126/science.1233665 · Cited by 375
Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection
Nandi, B., & Behar, S. M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110919 · Cited by 373
Kaforou, M., Wright, V., Oni, T., French, N., Anderson, S. T. B., Bangani, N., Banwell, C. M., Brent, A., Crampin, A. C., Dockrell, H. M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001538 · Cited by 374
Self-citationT cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 370
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Lenaerts, A. J. M., Barry, C. E., & Dartois, V. A. (2015) · Immunological Reviews · doi:10.1111/imr.12252 · Cited by 371
Immune Response to Mycobacterium tuberculosis: A Narrative Review
de Martino, M., Lodi, L., Galli, L., & Chiappini, E. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00350 · Cited by 356
The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion
Ehlers, S., & Schaible, U. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00411 · Cited by 373
Day, C. L., Abrahams, D. A., Lerumo, L., van Rensburg, E. J., Stone, L., O’rie, T., Pienaar, B., de Kock, M., Kaplan, G., Mahomed, H., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101122 · Cited by 344
Yan, J., Risacher, S. L., Shen, L., & Saykin, A. J. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx066 · Cited by 358
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
Walzl, G., McNerney, R., du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. I. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30111-7 · Cited by 343
Mattila, J. T., Ojo, O. O., Kepka‐Lenhart, D., Marino, S., Kim, J. H., Eum, S. Y., Via, L. E., Barry, C. E., Klein, E. C., Kirschner, D. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300113 · Cited by 340
Sweeney, T. E., Shidham, A., Wong, H. R., & Khatri, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5993 · Cited by 346
Parsing the interferon transcriptional network and its disease associations
Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., Raj, T., Ye, C. J., Chevrier, N., Zhang, S.-Y., Feng, T., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.032 · Cited by 337
New insights into the evasion of host innate immunity by Mycobacterium tuberculosis
Chai, Q., Wang, L., Liu, C. H., & Ge, B. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0502-z · Cited by 347
The Roles of Type I Interferon in Bacterial Infection
Boxx, G. M., & Cheng, G. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.016 · Cited by 335
Sweeney, T. E., Wong, H. R., & Khatri, P. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7165 · Cited by 334
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Raviglione, M. C., Marais, B. J., Floyd, K., Lönnroth, K., Getahun, H., Migliori, G. B., Harries, A. D., Nunn, P. P., Lienhardt, C., Graham, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60727-2 · Cited by 334
IL-17 and Th17 cells in tuberculosis
Torrado, E., & Cooper, A. M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.004 · Cited by 340
Horsburgh, C. R., Barry, C. E., & Lange, C. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1413919 · Cited by 324
The ongoing challenge of latent tuberculosis
Esmail, H., Barry, C. E., Young, D. B., & Wilkinson, R. J. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0437 · Cited by 341
Self-citationHerberg, J. A., Kaforou, M., Wright, V., Shailes, H., Eleftherohorinou, H., Hoggart, C., Cebey‐López, M., Carter, M. J., Janes, V. A., Gormley, S., et al. (2016) · JAMA · doi:10.1001/jama.2016.11236 · Cited by 323
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 337
Common patterns and disease-related signatures in tuberculosis and sarcoidosis
Maertzdorf, J., Weiner, J. M., Mollenkopf, H., T. Accelerating Medicines Partnership in RA SLE Network, Bauer, T. T., Prasse, A., Müller–Quernheim, J., Kaufmann, S. H. E., Bellinger, O., Diel, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121072109 · Cited by 320
The immunoregulatory landscape of human tuberculosis granulomas
McCaffrey, E., Donato, M., Keren, L., Chen, Z., Delmastro, A. C., Fitzpatrick, M. B., Gupta, S., Greenwald, N. F., Baranski, A., Graf, W., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01121-x · Cited by 334
Biological Differences Between the Sexes and Susceptibility to Tuberculosis
Nhamoyebonde, S., & Leslie, A. J. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu147 · Cited by 314
Mejias, A., Dimo, B., Suarez, N. M., Garcia, C., Suarez-Arrabal, M. C., Jartti, T., Blankenship, D., Jordan-Villegas, A., Ardura, M. I., Xu, Z., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001549 · Cited by 313
Self-citationFerreira, R. C., Guo, H., Coulson, R., Smyth, D. J., Pękalski, M. Ł., Burren, O. S., Cutler, A. J., Doecke, J. D., Flint, S. M., McKinney, E. F., et al. (2014) · Diabetes · doi:10.2337/db13-1777 · Cited by 323
Neutrophils in tuberculosis: friend or foe?
Lowe, D. M., Redford, P. S., Wilkinson, R. J., O’Garra, A., & Martineau, A. R. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.10.003 · Cited by 312
Self-citationVitamin D accelerates resolution of inflammatory responses during tuberculosis treatment
Coussens, A. K., Wilkinson, R. J., Hanifa, Y., Nikolayevskyy, V., Elkington, P. T., Islam, K., Timms, P. M., Venton, T. R., Bothamley, G. H., Packe, G. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200072109 · Cited by 310
Self-citationIn search of a new paradigm for protective immunity to TB
Nunes-Alves, C., Booty, M. G., Carpenter, S. M., Jayaraman, P., Rothchild, A. C., & Behar, S. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3230 · Cited by 320
Bloom, C. I., Graham, C. M., Berry, M. P. R., Rozakeas, F., Redford, P. S., Wang, Y., Xu, Z., Wilkinson, K. A., Wilkinson, R. J., Kendrick, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070630 · Cited by 301
Self-citationRole of innate cytokines in mycobacterial infection
Cooper, A. M., Mayer-Barber, K. D., & Sher, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.13 · Cited by 309
MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment
Dorhoi, A., Iannaccone, M., Farinacci, M., Fae, K. C., Schreiber, J., Moura‐Alves, P., Nouailles, G., Mollenkopf, H., Oberbeck‐Müller, D., Jörg, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67604 · Cited by 302
Yang, C.-T., Cambier, C. J., Davis, J. M., Hall, C. J., Crosier, P. S., & Ramakrishnan, L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.009 · Cited by 293
The balance between protective and pathogenic immune responses in the TB-infected lung
Orme, I. M., Robinson, R., & Cooper, A. M. (2014) · Nature Immunology · doi:10.1038/ni.3048 · Cited by 295
Neutrophils in innate and adaptive immunity
Jaillon, S., Galdiero, M. R., Prete, D. D., Cassatella, M. A., Garlanda, C., & Mantovani, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0374-8 · Cited by 294
Deriu, E., Boxx, G. M., He, X., Pan, C., Benavidez, S. D., Cen, L., Rozengurt, N., Shi, W., & Cheng, G. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005572 · Cited by 280
Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
Mishra, B. B., Lovewell, R. R., Olive, A. J., Zhang, G., Wang, W., Eugenín, E. A., Smith, C. M., Phuah, J. Y., Long, J. E., Dubuke, M. L., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.72 · Cited by 285
Obermoser, G., Presnell, S., Domico, K., Xu, H., Wang, Y., Anguiano, E., Thompson-Snipes, L., Ranganathan, R., Zeitner, B., Bjork, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.008 · Cited by 279
Self-citationIFN-Inducible GTPases in Host Cell Defense
Kim, B.-H., Shenoy, A. R., Kumar, P., Bradfield, C. J., & MacMicking, J. D. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.007 · Cited by 287
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rappuoli, R., & Aderem, A. A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 275
Type I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K. D., Sher, A., & O’Garra, A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 284
Self-citationThe risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Bumbăcea, D., Arend, S. M., Eyüboğlu, F. Ö., Fishman, J. A., Goletti, D., Ison, M. G., Jones, C. E., Kampmann, B., Kotton, C. N., Lange, C. G., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00000712 · Cited by 269
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Wallis, R. S., O’Garra, A., Sher, A., & Wack, A. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00734-z · Cited by 277
Self-citationThe science and medicine of human immunology
Pulendran, B., & Davis, M. M. (2020) · Science · doi:10.1126/science.aay4014 · Cited by 273
Dey, B., Dey, R. J., Cheung, L. S., Pokkali, S., Guo, H., Lee, J., & Bishai, W. R. (2015) · Nature Medicine · doi:10.1038/nm.3813 · Cited by 273
S100A8/A9 Proteins Mediate Neutrophilic Inflammation and Lung Pathology during Tuberculosis
Gopal, R., Monin, L., Torres‐García, D., Slight-Webb, S. R., Mehra, S., McKenna, K. C., Junecko, B. A. F., Reinhart, T. A., Kolls, J. K., Báez-Saldaña, R., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0803oc · Cited by 266
Howerton, C. L., Morgan, C. P., Fischer, D. B., & Bale, T. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300065110 · Cited by 257
Metadata
- Authors
- Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J. J., Mejias, A., Ramilo, O., Kon, O. M., Pascual, V., Banchereau, J., Chaussabel, D., & O’Garra, A.
- Affiliations
- National Institute for Medical Research (GB)
- Inserm (FR)
- Imperial College Healthcare NHS Trust (GB)
- University of Cape Town (ZA)
- The University of Texas Southwestern Medical Center (US)
- Baylor Scott & White Health (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- O’Garra, Anne
- ORCID
- Venue
- Nature
- Published
- 2010-08
- Volume
- 466
- Issue
- 7309
- Pages
- 973-977
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3492754
- OpenAlex
- W2109543073
- Cited by
- 1,898
- References
- 29
- Citations by year
- 2026: 104 · 2025: 105 · 2024: 112 · 2023: 108 · 2022: 99 · 2021: 121 · 2020: 113 · 2019: 127 · 2018: 137 · 2017: 134 · 2016: 149 · 2015: 126 · 2014: 119 · 2013: 127 · 2012: 114
- FWCI
- 70.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust (088316, 84323)
- Imperial College Healthcare NHS Trust
- U.S. Public Health Service (U19 AIO57234-02, P50 ARO54083)
- Medical Research Council
- National Cancer Institute (P01CA084512)
- National Institute of Allergy and Infectious Diseases (U19AI057234, U01AI082110, U19AI082715)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR050770, P50AR054083)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- tuberculosis, Mycobacterium tuberculosis, latent tuberculosis infection, active tuberculosis, whole blood transcriptome, interferon-stimulated genes, neutrophils, interferon-gamma signaling, type I interferon, transcriptomic biomarkers, diagnostic biomarkers, prognostic factors, systemic lupus erythematosus, cell composition, treatment response monitoring
- MeSH terms
- Blood, Gene Expression Regulation, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Mycobacterium tuberculosis, Neutrophils, Transcription, Genetic, Tuberculosis, Tuberculosis, Pulmonary, Signal Transduction, Case-Control Studies, Gene Expression Profiling, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
